These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24452990)

  • 1. Prevention and early treatment of peritoneal metastases from colorectal cancer: second-look laparotomy or prophylactic HIPEC?
    Baratti D; Kusamura S; Deraco M
    J Surg Oncol; 2014 Mar; 109(3):225-6. PubMed ID: 24452990
    [No Abstract]   [Full Text] [Related]  

  • 2. Colorectal Cancer Peritoneal Metastases: Second-look Laparotomy, Prophylactic HIPEC, or Both?
    Baratti D; Kusamura S; Deraco M
    Ann Surg; 2016 Jan; 263(1):e5. PubMed ID: 24887973
    [No Abstract]   [Full Text] [Related]  

  • 3. Early intervention for treatment and prevention of colorectal carcinomatosis: a plan for individualized care.
    Sugarbaker PH
    Surg Oncol Clin N Am; 2012 Oct; 21(4):689-703. PubMed ID: 23021724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized clinical trials for colorectal cancer peritoneal surface malignancy.
    Avital I; Brücher BL; Nissan A; Stojadinovic A
    Surg Oncol Clin N Am; 2012 Oct; 21(4):665-88. PubMed ID: 23021723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIPEC + EPIC versus HIPEC-alone: differences in major complications following cytoreduction surgery for peritoneal malignancy.
    McConnell YJ; Mack LA; Francis WP; Ho T; Temple WJ
    J Surg Oncol; 2013 May; 107(6):591-6. PubMed ID: 23129533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consensus statement on the loco regional treatment of colorectal cancer with peritoneal dissemination.
    Esquivel J; Elias D; Baratti D; Kusamura S; Deraco M
    J Surg Oncol; 2008 Sep; 98(4):263-7. PubMed ID: 18726889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritoneal metastases from colorectal cancer: patient selection for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Riss S; Mohamed F; Dayal S; Cecil T; Stift A; Bachleitner-Hofmann T; Moran B
    Eur J Surg Oncol; 2013 Sep; 39(9):931-7. PubMed ID: 23810280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment-related morbidity and toxicity of CRS and oxaliplatin-based HIPEC compared to a mitomycin and doxorubicin-based HIPEC protocol in patients with peritoneal carcinomatosis: a matched-pair analysis.
    Glockzin G; von Breitenbuch P; Schlitt HJ; Piso P
    J Surg Oncol; 2013 May; 107(6):574-8. PubMed ID: 22833286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iterative procedures combining cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal recurrence: postoperative and long-term results.
    Golse N; Bakrin N; Passot G; Mohamed F; Vaudoyer D; Gilly FN; Glehen O; Cotte E
    J Surg Oncol; 2012 Aug; 106(2):197-203. PubMed ID: 22331814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of peritoneal carcinomatosis from colorectal cancer: a critical issue.
    Sammartino P; Sibio S; Accarpio F; Di Giorgio A
    Ann Surg; 2014 Mar; 259(3):e51. PubMed ID: 24263309
    [No Abstract]   [Full Text] [Related]  

  • 11. Reply to letter: "Prevention of peritoneal carcinomatosis from colorectal cancer: a critical issue".
    Goéré D; Elias D
    Ann Surg; 2014 Mar; 259(3):e52. PubMed ID: 24263312
    [No Abstract]   [Full Text] [Related]  

  • 12. Current status and future directions in the treatment of peritoneal dissemination from colorectal carcinoma.
    Elias D; Quenet F; Goéré D
    Surg Oncol Clin N Am; 2012 Oct; 21(4):611-23. PubMed ID: 23021719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Peritoneal carcinomatosis of colorectal cancer: cytoreductive surgery and hyperthermic intraperitoneal chemotherapy].
    Königsrainer I; Beckert S; Brücher B; Zieker D; Königsrainer A
    Dtsch Med Wochenschr; 2011 Sep; 136(36):1811-4. PubMed ID: 21882140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of cytoreduction followed by HIPEC in carcinomatosis of colorectal origin.
    Verwaal VJ
    Cancer Treat Res; 2007; 134():291-301. PubMed ID: 17633061
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis: prognosis and treatment of recurrences in a cohort study.
    Cashin PH; Graf W; Nygren P; Mahteme H
    Eur J Surg Oncol; 2012 Jun; 38(6):509-15. PubMed ID: 22475555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re: Verwaal VJ, van Tinteren H, Ruth SV, et al.: Toxicity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy. J Surg Oncol 2004; 85:61-67.
    Sugarbaker PH
    J Surg Oncol; 2004 Dec; 88(4):276-8. PubMed ID: 15565559
    [No Abstract]   [Full Text] [Related]  

  • 17. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.
    Verwaal VJ; Bruin S; Boot H; van Slooten G; van Tinteren H
    Ann Surg Oncol; 2008 Sep; 15(9):2426-32. PubMed ID: 18521686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer.
    Glockzin G; Ghali N; Lang SA; Schlitt HJ; Piso P
    J Surg Oncol; 2009 Sep; 100(4):306-10. PubMed ID: 19697436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curative treatment of colorectal peritoneal carcinomatosis: current status and future trends.
    Maggiori L; Elias D
    Eur J Surg Oncol; 2010 Jul; 36(7):599-603. PubMed ID: 20605396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Summary of current therapeutic options for peritoneal metastases from colorectal cancer.
    Chua TC; Esquivel J; Pelz JO; Morris DL
    J Surg Oncol; 2013 May; 107(6):566-73. PubMed ID: 22688776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.